Showing results (231-240 of 318) with videos related to
Sort By:
Pageof 32
Journal of the National Cancer Institute. Monographs|June 12, 2015
Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1α and Relation to Clinical ResponseDaniele Generali, Alfredo Berruti, Maria Rosa Cappelletti, et al.JAMA Oncology|July 13, 2023
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical TrialElisabetta Munzone, Meredith M Regan, Saverio Cinieri, et al.ESMO Open|August 21, 2020
Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort studyEva Blondeaux, Arlindo R Ferreira, Francesca Poggio, et al.British Journal of Cancer|April 2, 2020
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 studyEva Blondeaux, Matteo Lambertini, Andrea Michelotti, et al.Journal of Translational Medicine|October 10, 2015
Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell linesSilvia Boero, Anna Morabito, Barbara Banelli, et al.Clinical Breast Cancer|May 17, 2011
Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trialNicholas J Robert, Mansoor N Saleh, Devchand Paul, et al.JCO Global Oncology|February 2, 2021
Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in OncologyConcetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, et al.Gene|July 20, 2024
Assessing the efficacy of an innovative diagnostic method for identifying 5 % variants in somatic ctDNAChiara Mareso, Luca Crosta, Mattia Giovanna De Vita, et al.The Lancet. Oncology|September 9, 2019
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysisMario Giuliano, Francesco Schettini, Carla Rognoni, et al.Proceedings of the National Academy of Sciences of the United States of America|July 20, 2011
Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737Samantha R Oakes, François Vaillant, Elgene Lim, et al.Pageof 32